| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/19/1997 | EP0763050A1 Branched oligonucleotides as pathogen-inhibitory agents |
| 03/19/1997 | EP0763049A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 03/19/1997 | EP0763048A1 Post exposure prevention of hiv |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763017A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
| 03/19/1997 | EP0762895A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 03/19/1997 | EP0762884A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 03/19/1997 | EP0762880A1 Retroviral protease inhibitor combinations |
| 03/19/1997 | EP0762878A1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection |
| 03/19/1997 | EP0762876A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 03/19/1997 | EP0751948A4 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 03/19/1997 | EP0642344B1 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 03/19/1997 | EP0606336B1 Process for making antimicrobial quinolonyl lactams |
| 03/19/1997 | EP0566590B1 Particulates |
| 03/19/1997 | EP0445135B1 Immogenically active fractions of borrelia burgdorferi |
| 03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145621A Benzamide derivative, compsn. containing said derivative and use thereof |
| 03/19/1997 | CN1145587A Protease inhibitors |
| 03/19/1997 | CN1145366A Prepn. method and preparation for "Babao su" a new anti-virus compound |
| 03/19/1997 | CN1145238A Wuling C-hepatitis powder |
| 03/19/1997 | CN1145223A Endothelin receptor antagonists |
| 03/19/1997 | CN1145168A In ovo vaccination against coccidiosis |
| 03/18/1997 | US5612487 Viricides, antigens and tobacco plants |
| 03/18/1997 | US5612477 Antibiotics |
| 03/18/1997 | US5612476 Anti-endotoxin compounds |
| 03/18/1997 | US5612453 Viricides |
| 03/18/1997 | US5612352 Inhibitors of squalene synthase and anticholesterol agents with biphenylquinuclidine derivatives |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612340 Pyrimidineamine derivatives and processes for the preparation thereof |
| 03/18/1997 | US5612333 4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl(1h)pyrimidin-2 -one and 11-cyclopropyl-5,11-dihydro-4-methyl-6hdipyrido(3,3b (1,4)diazipine-6-one |
| 03/18/1997 | US5612330 Herpes virus |
| 03/18/1997 | US5612316 Treatment of resistance to transplantation, fungal infections, and autoimmune diseases |
| 03/18/1997 | US5612217 Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitors |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/18/1997 | US5612042 Vaccine against streptococcus suis infection |
| 03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
| 03/18/1997 | US5611793 Disinfecting or sterilization tissues of mouths or wounds by applying photosensitizers |
| 03/18/1997 | CA2093045C Method for preparing low free formaldehyde methylolhydantoins and compositions thereof |
| 03/18/1997 | CA2085136C Method for inhibition of retroviral replication |
| 03/18/1997 | CA2076980C Method and product for promoting hair growth and treating skin conditions |
| 03/18/1997 | CA2008341C Benzocycloalcenyl dihydroxy alcanoic acid derivatives, process for their preparation and drugs containing the same |
| 03/13/1997 | WO1997009442A1 Targeted nucleotide sequence delivery and integration system |
| 03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | WO1997009349A1 Binding protein |
| 03/13/1997 | WO1997009328A1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| 03/13/1997 | WO1997009053A1 2-deoxystreptamine as a molecular scaffold for preparing functionally and spatially diverse molecules and pharmaceutical compositions thereof |
| 03/13/1997 | WO1997009043A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | WO1997009042A1 Pharmaceutical formulation |
| 03/13/1997 | WO1997003345A3 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2231788A1 Targeted nucleotide sequence delivery and integration system |
| 03/13/1997 | CA2231114A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | CA2228647A1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| 03/13/1997 | CA2228003A1 2-deoxystreptamine as a molecular scaffold for preparing functionally and spatially diverse molecules and pharmaceutical compositions thereof |
| 03/13/1997 | CA2227301A1 Hcv binding protein |
| 03/13/1997 | CA2184971A1 Cephalosporin derivatives |
| 03/12/1997 | EP0761684A2 Alanine substitution analogues of magainin peptides |
| 03/12/1997 | EP0761672A1 Cephalosporin containing in position 7 a substituted benzyloxyimino radical, processes for their preparation and intermediates for their preparation, their use as medicaments |
| 03/12/1997 | EP0761671A1 Cephem derivatives |
| 03/12/1997 | EP0761667A1 Heterocyclic substituted pseudopeptides |
| 03/12/1997 | EP0761230A2 Vaccine containing Bordetella pertussis outer membrane protein, and method of making such vaccine |
| 03/12/1997 | EP0761226A1 Method of potentiating antibiotics with polyphenols |
| 03/12/1997 | EP0761218A1 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate |
| 03/12/1997 | EP0761215A1 Antibacterial agent |
| 03/12/1997 | EP0761095A2 A new skin preparation composition |
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
| 03/12/1997 | EP0760855A1 Hepatitis c virus asialoglycoproteins |
| 03/12/1997 | EP0760822A1 Anti-fungal cyclic depsipeptides |
| 03/12/1997 | EP0760820A1 Cephalosporin compounds and processes for the preparation thereof |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760674A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
| 03/12/1997 | EP0760673A1 INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS |
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760652A1 Compositions for neutralization of lipopolysaccharides |
| 03/12/1997 | EP0760650A1 Antimicrobial oil-in-water emulsions |
| 03/12/1997 | EP0538283B1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 03/12/1997 | EP0468997B1 Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 03/12/1997 | CN1145067A Anti-helicombacter ester and carbamate derivatives of azolones |
| 03/12/1997 | CN1145033A Human therapeutic uses of BPI protein products |
| 03/12/1997 | CN1144690A Keep-clean agent and its moist-retaining tissues |
| 03/12/1997 | CN1144662A Medicine composition for treatment of cold |
| 03/12/1997 | CN1034216C 7-(substituted)-9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 03/11/1997 | US5610308 Process for preparing intermediates for thrombin inhibitors |
| 03/11/1997 | US5610300 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates |
| 03/11/1997 | US5610294 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 03/11/1997 | US5610279 Human TNF receptor |
| 03/11/1997 | US5610196 Methyl unsaturated long-chain alkyl ketone, acne |
| 03/11/1997 | US5610139 Peptide from horseshoe crab extract, antibiotic, staphylococcus |
| 03/11/1997 | US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus |